Legend Biotech (NASDAQ: LEGN) reported Q1 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $195.05 million versus the consensus estimate of $192.54 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.